MeiraGTx Holdings plc (MGTX) Buy Target $17.29 Sell Target $19.46

Trade Setup

Buy Target $17.29
Sell Target $19.46

MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson’s diseases.


X